Cargando…
Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL
Pancreatic cancer cells show varying sensitivity to the anticancer effects of gemcitabine. However, as a chemotherapeutic agent, gemcitabine can cause intolerably high levels of toxicity and patients often develop resistance to the beneficial effects of this drug. Combination studies show that use o...
Autores principales: | Elia, Androulla, Henry-Grant, Ricky, Adiseshiah, Charlotte, Marboeuf, Catherine, Buckley, Rebecca J, Clemens, Michael J, Mudan, Satvinder, Pyronnet, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870593/ https://www.ncbi.nlm.nih.gov/pubmed/29233971 http://dx.doi.org/10.1038/s41419-017-0001-z |
Ejemplares similares
-
Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment
por: Rimmer, Ella, et al.
Publicado: (2022) -
Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells
por: Teng, Y, et al.
Publicado: (2014) -
4E-BP restrains eIF4E phosphorylation
por: Müller, David, et al.
Publicado: (2013) -
Differential Regulation of the Three Eukaryotic mRNA Translation Initiation Factor (eIF) 4Gs by the Proteasome
por: Alard, Amandine, et al.
Publicado: (2019) -
Requirement for the eIF4E Binding Proteins for the Synergistic Down-Regulation of Protein Synthesis by Hypertonic Conditions and mTOR Inhibition
por: Clemens, Michael J., et al.
Publicado: (2013)